source
- STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and moreLilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop the price breaksSTAT · 1mo ago↗ source
- AbiVax falls as safety worries cloud ‘landmark’ immune drug resultsA handful of cancer cases reported among treatment recipients overshadowed efficacy results analysts described as “best-in-disease” and sent shares down more than 30%.BioPharma Dive · 1mo ago↗ source
- How one state’s medical meal program lowered health care costsMedicaid work requirements, fast-tracked funding for experimental Ebola vaccines, and more health news from Morning RoundsSTAT · 1mo ago